Reed's (REED) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
14 Jan, 2026Executive summary
Net sales for Q3 2024 declined to $6.8 million from $11.9 million year-over-year, mainly due to production limitations, short shipments, and restricted working capital and liquidity constraints.
Gross profit dropped to $1.2 million (18% margin) from $4.0 million (34% margin) in Q3 2023, impacted by higher trade spend, increased cost of goods sold, and supply chain challenges.
Operating loss widened to $3.1 million ($0.62/share) from $0.1 million ($0.03/share) in Q3 2023; Modified EBITDA loss was $3.0 million versus $0.2 million profit year-over-year.
Net loss was $4.2 million in Q3 2024 compared to $1.4 million in Q3 2023; nine-month net loss was $9.0 million, similar to prior year.
E-commerce sales exceeded $70,000 monthly for two consecutive months, with projections of over $1 million in 2025.
Financial highlights
Q3 2024 net sales: $6.8 million (-43% YoY); nine months: $28.2 million (-15% YoY).
Q3 gross profit: $1.2 million (-70% YoY); nine months: $8.5 million (-8% YoY).
Q3 operating loss: $3.1 million (vs. $0.1 million prior year); nine months: $4.5 million (flat YoY).
Q3 net loss: $4.2 million (vs. $1.4 million prior year); nine months: $9.0 million (vs. $8.9 million prior year).
Cash from operating activities was $1.1 million, up from cash used of $1.8 million in Q3 2023, driven by lower inventory purchases.
Outlook and guidance
The previously issued full-year 2024 outlook has been withdrawn due to ongoing inventory challenges.
With new capital and a deleveraged balance sheet, management aims to rebuild inventory and drive sustained growth and profitability in 2025.
Management expects continued margin improvement from cost actions and supply chain initiatives.
Inflation and supply chain volatility remain risks, but moderation in freight and input costs is anticipated.
Company is evaluating funding alternatives and restructuring debt to address upcoming maturities.
Latest events from Reed's
- Sequential improvements and new growth initiatives set the stage for margin expansion in 2026.REED
Q4 202525 Mar 2026 - Q2 2024 saw double-digit sales growth, margin gains, and improved but still risky profitability.REED
Q2 20241 Feb 2026 - Financial restructuring and product innovation set the stage for strong growth in 2025.REED
The Sidoti Small-Cap Virtual Investor Conference11 Jan 2026 - Gross margin hit 30% as debt fell and new products and capital set up 2025 growth.REED
Q4 202426 Dec 2025 - Five-year warrants with cash/cashless exercise, anti-dilution, and strong investor protections.REED
Registration Filing4 Dec 2025 - IPO offers shares and warrants to fund growth amid ongoing losses and pending NYSE listing.REED
Registration Filing2 Dec 2025 - Registration enables resale of 18.8M shares after major financings and debt conversions.REED
Registration Filing29 Nov 2025 - Registering 5M shares for resale after $5M placement; expanding in health-focused beverages.REED
Registration Filing29 Nov 2025 - 18.8 million shares registered for resale as company targets growth in natural beverages.REED
Registration Filing29 Nov 2025